The SET domain bifurcated histone lysine methyltransferase 2 (SETDB2) mediated the formation of repressive mark trimethylated H3K9 (H3K9me3), which was reported to be associated with tumor‐related phenotypes.21, 22. This evidence concerns the gene SETDB2 and neoplasm.